COMPARISON BETWEEN LERGOTRILE AND BROMOCRIPTINE IN PARKINSONISM

被引：35

作者：

TEYCHENNE, PF

PFEIFFER, RF

BERN, SM

MCINTURFF, D

CALNE, DB

机构：

[1] NINCDS,EXPTL THERAPEUT BRANCH,BETHESDA,MD 20014

[2] NIH,DEPT PHARM,BETHESDA,MD 20014

来源：

ANNALS OF NEUROLOGY | 1978年 / 3卷 / 04期

关键词：

D O I：

10.1002/ana.410030408

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：319 / 324

页数：6

共 27 条

[1] BROMOCRIPTINE IN PARKINSONISM [J].

CALNE, DB ;

TEYCHENNE, PF ;

CLAVERIA, LE ;

EASTMAN, R ;

GREENACRE, JK ;

PETRIE, A .

BMJ-BRITISH MEDICAL JOURNAL, 1974, 4 (5942) :442-444

[2]

CALNE DB, 1969, LANCET, V2, P973

[3]

CALNE DB, 1974, LANCET, V2, P1355

[4]

CALNE DB, 1975, THERAPEUTICS NEUROLO, P202

[5] INHIBITION OF PROLACTIN SECRETION BY LERGOTRILE MESYLATE - MECHANISM OF ACTION [J].

CLEMENS, JA ;

SMALSTIG, EB ;

SHAAR, CJ .

ACTA ENDOCRINOLOGICA, 1975, 79 (02) :230-237

[6] EFFECT OF ERGOT DRUGS ON CENTRAL CATECHOLAMINE NEURONS - EVIDENCE FOR A STIMULATION OF CENTRAL DOPAMINE NEURONS [J].

CORRODI, H ;

FUXE, K ;

HOKFELT, T ;

LIDBRINK, P ;

UNGERSTEDT, U .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (05) :409-412

[7] STEREOSPECIFICITY OF INTERACTION OF NEUROLEPTIC DRUGS WITH NEUROTRANSMITTERS AND CORRELATION WITH CLINICAL POTENCY [J].

ENNA, SJ ;

BENNETT, JP ;

BURT, DR ;

CREESE, I ;

SNYDER, SH .

NATURE, 1976, 263 (5575) :338-341

[8]

FLUCKIGER E, 1976, PHARM CLIN ASPECTS B, P12

[9] EFFECT OF CB-154 (2-BROMO-ALPHA-ERGOCRYPTINE) ON PARALYSIS AGITANS COMPARED WITH MADOPAR IN A DOUBLE-BLIND, CROSSOVER TRIAL [J].

GERLACH, J .

ACTA NEUROLOGICA SCANDINAVICA, 1976, 53 (03) :189-200

[10] COMPARISON OF EFFECTS OF BROMOCRIPTINE AND LEVODOPA IN PARKINSONS-DISEASE [J].

GODWINAUSTEN, RB ;

SMITH, NJ .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1977, 40 (05) :479-482

← 1 2 3 →